Stay updated on AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.

Latest updates to the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page, which appears to be a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a consolidated Locations section listing trial sites in Maryland, Missouri, North Carolina, Tennessee, Texas, Wisconsin, and Ontario, and updated the page revision to v3.3.3. The previous per-location subsections and the HHS Vulnerability Disclosure section were removed.SummaryDifference0.7%

- Check48 days agoChange DetectedRevision: v3.3.2 shown; no other content changes are evident.SummaryDifference0.0%

- Check55 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed and the revision label updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA general funding-status notice was removed from the page; all study details and core content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check77 days agoChange DetectedMinor layout/formatting adjustments on the Study Details page; no changes to eligibility criteria, interventions, primary or secondary outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.